Elasticity Face Cream Base

1. INCI & CAS

INCI: Bakuchiol · CAS: 10309-37-2

2. Role in the formula

Bakuchiol is listed as a cosmetic conditioning ingredient in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Palmitoyl Tripeptide-1. Review its role in this formula without treating it as retinol or assuming equivalent results.

3. Typical use levels (formulation guide)

• For the reference allocation, the recorded amount is 0.5% w/w.

Oil-soluble. Add in cool-down and protect from light.

4. Regulatory sources & global compliance

• Treat this information as a development reference; it establishes no approval for the raw material or the final product; The completed formula is not approved by this reference.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; this reference is not approval for drug use or OTC marketing with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; evaluate packaging against the formula's susceptibility to oxidation; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The formulation note describes Bakuchiol as part of a cosmetic direction focused on bakuchiol.

• The development record does not substantiate drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The information about Bakuchiol cannot establish whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI & CAS

INCI: Palmitoyl Tripeptide-1 · CAS: 147732-56-7

2. Role in the formula

Palmitoyl Tripeptide-1 is listed as a cosmetic peptide in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Bakuchiol. Review the specified ingredient grade and evidence for the complete formula's intended claims.

3. Typical use levels (formulation guide)

• This entry shows a reference allocation of 0.08% w/w.

Follow the supplier blend TDS. Many trade blends are already diluted.

4. Regulatory sources & global compliance

• This formulation note is a guide for development; it should not be treated as authorization for the purchased grade or finished product; This is not authorization of a product as sold.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; no drug approval or OTC status is conferred by this entry so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; where oxidation is a concern, evaluate airless or pump packaging; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The formulation note describes Palmitoyl Tripeptide-1 as part of a cosmetic direction focused on peptide firming.

• This ingredient reference does not establish therapeutic effects, curative outcomes, or unsupported certification statements.
• The cosmetic guidance for Palmitoyl Tripeptide-1 cannot establish a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Bakuchiol and Palmitoyl Tripeptide-1. Review the contribution to body and application feel in the complete formula.

3. Typical use levels (formulation guide)

• The listed guide allocation for this component is 4% w/w.

Incorporate melted Butyrospermum Parkii Butter in the oil phase and maintain shear during cooling to reduce grain formation.

4. Regulatory sources & global compliance

• The ingredient entry serves as a development reference; it does not certify the supplied material or completed cosmetic; The reference does not authorize a finished product.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it makes no claim of drug or OTC authorization while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Protect the sealed bulk from heat, sun, and unnecessary exposure; where oxidation is a concern, evaluate airless or pump packaging; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The formulation note describes Butyrospermum Parkii Butter as part of a cosmetic direction focused on shea cushion.

• The development record cannot verify claims of drug action or cure, or a product certification outside the supporting records.
• The cosmetic guidance for Butyrospermum Parkii Butter cannot verify a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.